Massachusetts Mayor Charged With Taking Bribes in Exchange for Cannabis Licenses


Fall River Mayor Jasiel Correia, who became the old mill city’s youngest mayor when he was elected in 2015 at age 23, brazenly accepted cash bribes in exchange for issuing official letters needed to obtain a license to set up a cannabis business, authorities alleged.

At least four business owners paid a total of $600,000 in bribes to the mayor, and he used the money to support a lavish lifestyle and cover mounting legal bills, they said.

“Without hesitation, Mayor Correia was extorting marijuana vendor after marijuana vendor,” U.S. Attorney Andrew Lelling said at a news conference after the mayor’s arrest. “It’s striking the lengths he went to get the money, and the seeming indifference with how overt his activities were.”

In one instance, Lelling said, Correia walked into a vendor’s office and simply asked for $250,000 to issue one of the letters. Another time, Correia was paid $75,000 in cash while sitting in the backseat of a car. He promptly handed over a signed letter, Lelling said.

In a brief court appearance, Correia pleaded not guilty to the charges, which include bribery, extortion, wire fraud and filing false tax returns. A judge ordered him to post $25,000 of a $250,000 bond, and his travel was restricted to Massachusetts and Rhode Island.

“I’m not guilty of these charges. I’ve done nothing but good for the great city of Fall River,” Correia said outside the courthouse. “And I’m going to continue to do great things for the city.”

His lawyer, Kevin Reddington, said the indictment “reads like a bad John Grisham novel.”

He suggested that some of the government’s witnesses had criminal records and that the arrest was politically motivated. Correia is among three candidates in the mayoral primary Sept. 17.

“This is a case where there’s no corroboration, no physical evidence, no legitimate witness,” Reddington said. “The timing of this indictment is also troubling.”

Once a rising political star in Massachusetts, Correia has remained in office despite efforts to force him out amid his legal troubles. He was already facing charges on accusations that he stole investor funds to bankroll a lavish lifestyle. He has pleaded not guilty.


The latest investigation, which also involved agents from the FBI and the IRS, highlighted the potential for abuse in Massachusetts’ nascent retail marijuana industry, authorities said Friday.

Under state law, a so-called non-opposition letter is required to obtain a license to operate a marijuana business. The head of the local government issues the letters, which say that he or she has verified that the business is in a permissible zoning district.

Correia has issued at least 14 of the letters, including two for his current girlfriend’s brother, authorities said. It was not clear whether authorities were alleging that there was any illegal activity involved in the issuing of the letter to the brother.

State Inspector General Glenn Cunha said he hopes the indictment leads state marijuana regulators to consider additional safeguards.

Massachusetts voters approved the sale of recreational marijuana in 2016; the first storefronts opened last November.

Friday’s indictment also details other accusations against Correia. Authorities say the now-27-year-old mayor also accepted cash payments and a Rolex watch from a property owner to approve permits for his commercial building.

He also had his chief of staff, who also faces federal charges, give him half of her salary in return for allowing her to keep her city job, prosecutors said. It was not clear whether the staffer had a lawyer who could comment on the case.

Genoveva Andrade, a 48-year-old Somerset resident, faces similar extortion, theft and bribery as her former boss. She made her initial appearance Friday and wasn’t requried to enter a plea. Her lawyer declined to comment afterward.

Three other associates are also charged in the marijuana extortion scheme and will appear in court on another day.

In a strange turn of events this year, Correia was recalled by voters and then promptly reelected on the same night in March.

Correia pleaded not guilty in October to a 13-count indictment charging him with defrauding investors and filing false tax returns. Prosecutors say he collected more than $360,000 from investors to develop an app that was supposed to help businesses connect with consumers.

Instead, he allegedly spent more than $230,000 of the money on jewelry, designer clothing and a Mercedes, as well as on his political campaign and charitable donations.

A trial on those federal charges is to begin Feb. 24

The Cannabis industry and the impending fallout from vape related deaths


At least 450 people in 33 states had been afflicted as of Friday in addition to the five deaths, The Washington Post reported, citing federal health officials.

The states that have reported vaping-related lung illnesses to the Centers for Disease Control and Prevention (CDC) are Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Montana, Nebraska, New Jersey, New Mexico, New York, North Carolina, Ohio, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, West Virginia and Wisconsin.

One of the latest cases, reported Tuesday in Oregon, linked a man’s death in July to “reports that the individual … had recently used an e-cigarette or vaping device containing cannabis purchased from a cannabis dispensary,” according to a statement from the Oregon Health Authority (OHA).

An OHA spokesman wrote in an email to Marijuana Business Daily that authorities do not yet know the name of the store where the suspect cannabis was purchased but confirmed that it was a legal, licensed retailer.

“What we don’t know for sure is what, exactly, caused the individual’s death – just that the individual shopped at a dispensary before falling ill,” OHA spokesman Jonathan Modie wrote.

“We believe the individual used a vaping device containing a cannabis product before getting sick.”

The symptoms of the Oregon patient were consistent with those being investigated by the CDC and resemble other newly reported deaths in Illinois, Indiana and Minnesota as well as a possible vape-related death in Los Angeles County, according to The Washington Post.

Cause of illnesses remains unknown

No single vaping device, liquid or ingredient has been tied to all the illnesses, officials said.


Meanwhile, a preliminary report published Friday in the New England Journal of Medicine about pulmonary illness related to e-cigarette use in Illinois and Wisconsin noted 84% of the 53 case patients analyzed “reported having used tetrahydrocannabinol (THC) products in e-cigarette devices, although a wide variety of products and devices was reported.”

At this point, there are far more questions than answers, according to all the latest statements from the CDC and other health authorities.

“We’re all wondering if this is new or just newly recognized,” Dana Meaney-Delman of the CDC told reporters Friday.

An Illinois health official, Jennifer Layden, said officials there don’t know when such illnesses first began, but she said there has been a marked increase since spring.

The Washington Post reported that an additive, vitamin E acetate, was found in a number of cannabis samples tested in New York state, but The New York Times reported that some of the 100 products used by afflicted patients tested negative for that additive, so the precise cause of the illness still remains unclear to officials.

There’s even some dissent among marijuana industry watchers as to how big an impact the issue will have for the cannabis industry, even if state-legal marijuana vaporizer products are ultimately found not responsible.

Industry: True culprit is black market

The Oregon case notwithstanding, most of the other cases appear connected to cannabis products or e-cigarettes purchased from illicit dealers or unlicensed marijuana shops, to the point that the CDC has warned consumers not to buy or use vape products “off the street.”

As a consequence, state-legal cannabis vaporizer companies and other industry observers are taking to heart that blame for the outbreak may not fall on them.

“I’ve seen this kind of media blitz for the past 10 years happen once every six months,” said Arnaud Dumas de Rauly, CEO of New York-based The Blinc Group, a vaporizer company. “It’s all over the media for two, three, four weeks.

“This might last a little bit longer because it mixes nicotine vaping and cannabis, but I think it’s just a fad. It’s going to pass and everyone is going to forget about it in two months.”

Dumas de Rauly, who also chairs the ISO Committee on Vaping Standards and CEN Vaping Standards Committee, pointed to statements by both physicians watching the outbreak and a former commissioner of the U.S. Food and Drug Administration (FDA) noting the majority of illnesses were linked to street products diluted with some new additive, perhaps such as vitamin E acetate, as The Washington Post story indicated.

Vitamin E acetate is not used in standard cannabis oil or vape cartridge production, Dumas de Rauly said, and provides more evidence the problem is coming from illegal actors and not licensed cannabis companies.

“That is never used. Vitamin E is what we call a preservative. That’s what you add into cosmetics to make sure the product does not become spoiled,” Dumas de Rauly said.

“In no case is this a product that you should be inhaling.”

“When you add products like vitamin E … when you add different kind of lipid solvents to the mix, you’re making all of that oil stickier, and that stickiness is going to create these lung illnesses we’re seeing,” he said.

“Now, why do people add vitamin E? Because it’s supposed to help with the shelf life.”

That’s in direct contrast to lab-tested marijuana vape cartridges, which have been on the market for years without drastic health impacts reported, Dumas de Rauly noted.

“All of the patients are saying they bought it off the street. They didn’t buy it in legal, regulated environments,” Dumas de Rauly said.

“This is just basic math. … We have substantial data that shows that these products and these vaping illnesses come from the black market.

“The culprit here is the black-market product. It’s not the cartridge, it’s not the hardware, it’s not the regulators. It’s the black market.”

Collateral damage?

That doesn’t mean there won’t be people who point the finger at licensed cannabis businesses, however.


Longtime industry opponent Kevin Sabet, president of Smart Approaches to Marijuana (SAM), cited the Oregon case in a Twitter post Thursday: “Pot shops kill. Close them down.”

Morgan Paxhia, the managing director of San Francisco-based Poseidon Asset Management, warned the vaping illness outbreak “definitely could throw some cold water on the (vaping) space,” perhaps depending on how many more people get sick and how long the issue lasts.

But, Paxhia said, he doesn’t expect any drastic downturn in sales for marijuana vape cartridges or cannabis in general, in part because the vast majority of users haven’t reported negative side effects and the products remain incredibly popular.

“If people are getting sick from illicit-market products, pointing the blame at the legal operators is not going to correct the (situation),” he said. “It is likely an unfair characterization of those trying to do things properly and just causes more confusion.”

“But I do think it is a risk” that legal MJ companies could get scapegoated for the epidemic, Paxhia added.

Dumas de Rauly said he believes the outbreak could lead to a short-term drop in MJ vape cartridge sales, though he noted it’s unlikely it would hit the industry’s bottom line broadly over the long term.

Jim Makoso, vice president of Lucid Lab Group in Washington state, and Dumas de Rauly emphasized that numerous studies have concluded vaping is far safer than smoking when it comes to cannabis ingestion.

Makoso said that marijuana companies dedicated to making consumer-safe products will remain fine in the long haul, even if they need to invest in additional research and development or update manufacturing processes.

“In the short term, I anticipate that vape sales will pare back somewhat as a short-term response to what’s happening out there,” he said, “but by and large, there are very few connections to these illnesses and specifically cannabis products.

“Anytime that any product in the cannabis industry could be connected to an illness … we should take it very seriously. I don’t want to jump to conclusions, because at this point it’s just conjecture.”

Regulatory backlash?

There’s already been a crackdown in Michigan on flavored e-cigarette oils by Gov. Gretchen Whitmer, who said she was issuing a ban to keep such products from appealing to teenagers.

The move was motivated at least in part by the vaping-illness epidemic as part of a broader push to protect public health.

The ban could signal an expanded regulatory backlash against the vaping industry at large, marijuana industry watchers said.

Makoso noted the vaping-illness outbreak could even motivate the FDA or Congress to get directly involved in vaping industry oversight.

According to The Washington Post, U.S. Sen. Dick Durbin, a Democrat from Illinois, was calling Friday for FDA action.

Dumas de Rauly said further regulation is exactly where he sees the situation leading.

“The most impactful points for businesses are going to be the politicians and the regulatory agencies who are going to have to bump up their policing and enforcement of current regulations, if not create even more stringent” regulations to govern the vaping industry, he said.

“The idea of people getting sick specifically because of vaping … is definitely going to have an impact in the cannabis industry. What that impact is, is yet to be determined,” Makoso said.

Makoso and Dumas de Rauly said the best way for cannabis companies to get out in front of the situation is to talk about it as much as possible and educate the public on the rigorous testing that state-legal MJ products undergo to ensure consumer safety.

“This is what the cannabis industry should be using this story for,” Dumas de Rauly said. “This should prove that people need to go buy from legal, regulated sources.”

Mexico Moves Toward Cannabis Legalization with estimates of $12 billion from a Legal Market

Mexico Moves Toward Cannabis Legalization with estimates of $12 billion from a Legal Market

In a move expected to advance Mexico’s slow march toward decriminalizing cannabis, the nation’s Supreme Court has ordered the Health Ministry to draft regulations for medicinal cannabis use by mid-February.

Juan Francisco Torres Landa, who is Hogan Lovells’ office managing partner in Mexico City and has argued in favor of decriminalising cannabis for more than a decade, said the ruling, handed down in August, “sets the clock ticking” for the government to outline regulations for medicinal use after many bumps in the road.


At the same time, a proposal to regulate marijuana commercialization and use as a whole is under analysis in congress.

Advocates are hopeful that the administration of President Andres Manuel López Obrador, who took office on December 1, will decriminalize cannabis entirely after the previous administration blew through a court-ordered deadline to update the health and penal codes.

Interior Minister Olga Sánchez has called for decriminalization and regulation of all illicit drugs, including opium, so as to take away power from drug cartels.

Mexico is one of the biggest producers of illicit cannabis in the world, with the plant grown across thousands of acres. Much of that growth, though, is for the export market.

Market intelligence firm New Frontier Data puts the annual value of the Mexican cannabis market at $2 billion, with an estimated 1.4 million consumers (less than 1% of the total population). Mexican Sen. Cora Cecilia Pinedo Alonso says the Mexican market for legal cannabis could be worth $12 billion by 2029 – about half that of the current Canadian market.

The potential work for lawyers on legal cannabis ranges from advising the government on tax options and how to monitor the retail chain, to helping cannabis entrepreneurs secure permits, set parameters for product attributions and labeling, to sourcing raw materials and manufacturing.

Hogan Lovells is advising a number of cannabis prospects who want to be the first out of the gate once regulations are in place.


Drug prohibition is a “lousy” policy, said Torres Landa, who filed an amicus brief in favor of the most recent court ruling through his involvement with the Mexican Society for Responsible and Tolerant Personal Use, known by its Spanish acronym, SMART.

“We would rather have regulation in the hands of the government than organized crime,” he said.

As it stands, Mexican users of illicit drugs have no clarity on where those substances are produced or how strong they are. Nor is there a restriction on age for those who partake.

Cannabis users may appeal directly to the courts for individual permission to consume the plant and its derivatives.

“The fact that we call some drugs legal and some illegal is just a historic mistake,” said Torres Landa, who believes this dynamic allows drug traffickers to generate cash flow that fuels other, more unsavory activities.

Those activities include rampant extortion and demands by traffickers that bar owners offer exclusive distribution on their premises of drugs from one gang or another. The White Horse strip club in the Gulf state of Veracruz appears to have been set ablaze in the final days of August in retaliation against the management for not complying with demands from organized crime. Assailants blocked the exits and more than two dozen people died.

“We need to get the money out of the equation and weaken their structure,” Torres Landa said.

Twelve years of full-frontal combat against drug cartels has left many casualties. A 2019 Congressional Research Service report estimates that organized crime has played a role in roughly 150,000 murders – as many as half of all killings in Mexico – since former President Felipe Calderón launched the government’s drug war in 2006.

López Obrador has vowed not to take on the criminal chiefs.


Advocates for drug decriminalization believe cannabis could be the first of several illicit drugs that become legal in Mexico. Putting users in jail is a misuse of scarce government resources, they say, while targeting drug dealers diverts from fighting violent crime.

“The problem with the narrative of being very hard on drugs is that we’re not talking with the same magnitude about crimes that largely go unpunished, such as homicide and kidnapping,” said Lisa Sánchez, director of a civil organisation called Mexicans United Against Crime that has filed numerous legal briefs to support decriminalisation, alongside SMART.

Sánchez expects congress to decriminalize marijuana before the end of 2019.

Mexico’s high court has ruled five times that prohibition of recreational marijuana consumption is unconstitutional; the number of rulings sets an unusual precedent that should force Mexico’s congress to act.

A series of forums is scheduled for September to help legislators assess the landscape.

A top concern is how to track an eventual “legal” market for cannabis and what sort of taxes to levy on the products. Legislators will debate a framework similar to the so-called vice taxes on alcohol and tobacco that could generate much-needed revenue for the government.

Juvenal Lobato, a fiscal lawyer who has pushed for higher taxes on tobacco and sugary beverages, expects the government to adopt a mixed approach for cannabis that applies a flat percentage tax per value, gram, plant or seed – plus the country’s 16% sales tax.

Nearly 70% of the value of a package of cigarettes in Mexico goes toward taxes, which generates revenue while also serving as a disincentive for consumers to smoke.

But Lobato advises against slapping a similar “sin” tax on cannabis, at least initially.

“If you start with a high rate, you’re going to motivate the illicit market,” he says. Instead, he favors gradual tax hikes as legal cannabis finds its footing.

Lobato views the progress on cannabis as “the key to open the door” to a broader softening of drug laws and, he hopes, an eventual reduction in drug cartel-related violence.

Despite large-scale marijuana farming in patches of rural Mexico, cannabis is not massively popular in the country.

A 2018 survey by Mexico’s Center for Social Studies and Public Opinion said half of Mexicans polled oppose legalization of marijuana and seven out of 10 disapprove of its recreational use. When asked specifically about legal use for medicinal purposes, however, nearly 90% said that was acceptable.

Torres Landa dismisses suggestions that decriminalizing drugs like cannabis will result in a proliferation of the products, or their use, in Mexico.

“This will not expand the availability of drugs – it will allow government to monitor its use,” he said. “I’d rather have the government protecting us with a lot of information.”

Credit Unions are being reminded to allow accounts connected to Businesses in the Hemp Industry

Hemp businesses should have access to banking services, a top banking regulator reiterated this week amid ongoing complaints about banking and credit challenges in the newly legal industry.

The National Credit Union Association (NCUA), an independent federal agency that oversees and insures banking deposits for more than 100 million U.S. account holders, released a statement Monday reminding its member institutions that hemp businesses are legal.


“Hemp provides new opportunities for communities with an economic base involving agriculture,” the agency told banks.

However, the statement came along with an oft-repeated reminder that banks serving hemp businesses should include “appropriate due diligence procedures for hemp-related accounts.” That includes the Suspicious Activity Report, time-consuming documents to federal banking regulators that are cited by many banks as a reason they reject cannabis accounts.

The NCUA told banks it would update its hemp-banking guidance again this fall, after the U.S. Department of Agriculture releases national rules for growing hemp, which was removed from the Controlled Substances Act in December.

In April, several U.S. senators wrote to four federal banking and financial institutions – not the NCUA – asking them to ease banks’ concerns over accepting hemp accounts.

However, the letter did not change any rules from the U.S. Treasury Department about the paperwork involved in banking those businesses.

As a result, many hemp businesses say they are still struggling to access loans and other financial products.

In accordance of the new FDA ruling, Washington state bans all CBD-infused Foods & Beverages

Washington state banned the commercial sale of food and beverages containing CBD, sticking closely to U.S. Food and Drug Administration (FDA) policy.


The FDA currently stipulates that the cannabinoid cannot be an ingredient in the food supply, and the Washington State Department of Agriculture (WSDA) posted similar restrictions this month.

“To be clear, CBD is not currently allowed as a food ingredient, under federal and state law,” the state agency wrote.

Other hemp products are allowed in food, according to the WSDA.

Hemp ingredients the FDA has determined to be Generally Recognized as Safe (GRAS) based on federal requirements include hulled hempseeds, hempseed protein powder and hempseed oil.

Washington state agriculture officials said food manufacturers must remove CBD ingredients from their products and discontinue distribution of food products that contain them.

“If the FDA approves food ingredient uses for hemp extracts like CBD, those uses would be allowed under state law,” the WSDA noted.

FDA executive Lowell Schiller said at an industry event earlier this month that CBD treatments are promising but that far more research needs to be done before federal authorities can allow them in foods and dietary supplements.

New Advertising Policy enables Weedmaps to slip away from Class-Action Lawsuit

Weedmaps, a major online pot shop directory and cannabis marketplace, announced last week that it will finally no longer allow black-market businesses to advertise on its site. Weedmaps’ announcement follows months of complaints from licensed cannabis businesses of harm caused by Weedmaps’ inclusion of ads for unlicensed companies – namely, that allowing such companies’ product on the site really served to undercut the legal cannabis market. Now, following the lead of its competitors, Leafly, who said in early 2018 that it would bar unlicensed operators, Weedmaps also says it will end its practice.


Weedmaps, founded in 2008 and based in Irvine, California, is a well-known website for those in search of a local marijuana dispensary. Similar to Yelp, dispensaries can put up menus, photos, and other information on their products, and their customers can write comments and provide ratings. Where the marijuana market is more saturated, Weedmaps changes for higher placements in listings. Weedmaps has proven to be a user-friendly and favorite way to find any type of cannabis product. Some consumers can also order product online or even have it delivered to them via the platform.

California’s cannabis regulatory agencies have also attempted to regulate Weedmaps in the past, but they have had little success.  In February 2018, the Bureau of Cannabis Control sent Weedmaps a cease and desist letter telling the company it was breaking state law by including advertisements for unlicensed businesses. Weedmaps refused to change its policy at the time, citing Section 230 of the 1996 Communications Decency Act, which gives platforms like Facebook and YouTube safe harbor from being held liable for the content their users post. Notably, Section 230 has enabled the rapid growth of some of the biggest tech companies. Spokesperson for the Bureau, Alex Traverso, previously stated that after Weedmaps invoked Section 230, the Bureau instead chose to focus on regulating the illegal businesses directly.

The policy change was likely influenced by an impending class-action lawsuit that was in the works by the law firm of Zuber Lawler. The lawsuit, which would have been filed on behalf of the licensed cannabis businesses unhappy with Weedmaps’ policy, reportedly would have sought injunctive relief against Weedmaps under California’s Unfair Competition Law. California’s Unfair Competition Law prohibits false advertising and illegal business practices so, here, it likely would’ve alleged that Weedmaps’ advertising of unlicensed cannabis products constituted either or both.


For its own part, Weedmaps issued a news release and framed its announcement as part of a social justice initiative. It said that “later this year” it would begin requiring U.S. advertisers to provide a state license number on their listing, and that it would restrict the use of its point-of-sale system, online orders, delivery logistics and other services to licensed businesses exclusively. “These enhancements to existing safeguards on our platform will help patients and adult-use consumers find cannabis retailers that have provided evidence of state licensure,” Weedmaps Chief Executive, Chris Beals, said in the news release.

Weedmaps also indicated it would launch an initiative to support unlicensed, minority-owned marijuana businesses as they become licensed. “The company will provide a variety of free services and in-kind offerings to ensure that social equity entrepreneurs have the opportunity to compete in the industry.” The services and benefits Weedmaps will offer include professional development, ongoing coaching and professional support, resources such as compliance materials and standard operating procedures, and free software. “One of the most important and impactful promises of cannabis legalization is that it will give minority entrepreneurs the ability to enter the new industry and help reverse the damages inflicted on those disproportionately affected by the failed ‘War on Drugs,’” it said. “Unfortunately, as a result of limited access to capital and limited license opportunities provided by local governments, these entrepreneurs are actually finding it nearly impossible to participate in the legal market.”

Department of Justice Makes Plans to Hire More Cannabis Farmers for Study

The Justice Department said Monday it would move forward to expand the number of marijuana growers for federally authorized cannabis research.

The long-awaited move comes after researchers filed court papers asking a judge to compel the Drug Enforcement Administration to process the applications to grow research pot. The DEA began accepting applications to grow marijuana for federally approved research about three years ago, but the agency hasn't acted on the applications.

Both Republican and Democratic lawmakers in Congress have questioned why the Justice Department has taken so long to act. Attorney General William Barr had promised to look into the status of the applications in April.

Facing a deadline to respond to a court filing, the DEA signaled Monday it will process 33 applications with the goal of helping scientists develop "safe and effective drug products."

In June, applicant Scottsdale Research Institute in Arizona asked the U.S. Court of Appeals for the District of Columbia to order the DEA to process the applications. The court told the DEA to respond by Wednesday. Dr. Sue Sisley of the research institute said she considers this a victory.

For years, the University of Mississippi has been the only entity federally licensed to produce marijuana for research . Researchers have complained in recent years that the cannabis produced there is not like the cannabis sold in states where medical and so-called recreational marijuana is legal.

"This is why we filed this lawsuit: to get this program moving after three years of stagnancy," said Matthew Zorn, an attorney who represents the Scottsdale Research Institute.

The move announced Monday would give researchers a wider variety of cannabis to study, Uttam Dhillon, the DEA's acting administrator, said in a statement.

"DEA is making progress in the program to register additional marijuana growers for federally authorized research, and will work with other relevant federal agencies to expedite the necessary next steps," Dhillon said.

The agency is also planning to propose new regulations that would govern the program and help the agency evaluate the applications.

"I am pleased that DEA is moving forward with its review of applications for those who seek to grow marijuana legally to support research," Barr said.

Curaleaf Hit With Federal Class Action Lawsuit Alleging Securities Violations

Curaleaf Hit With Federal Class Action Lawsuit Alleging Securities Violations

The gravamen of the lawsuit is that Curaleaf violated federal securities law by making knowingly making materially false and misleading statements to the investing public that artificially inflated the market price of Curaleaf securities. The FDA sent a warning letter leading Curaleaf to delete all claims on its website and social media accounts of health claims about its CBD products.

In Honor of National CBD Day: we’re sharing some of our favorite Products.

In Honor of National CBD Day: we’re sharing some of our favorite Products.

If you’ve started exploring the world of CBD, you’ve probably come across three major types of CBD products — full spectrum, broad spectrum and isolate. It’s important to understand the difference before buying anything so you can make an informed decision.

Outside Lands Becomes First-Ever California Fest to Offer Cannabis Sales, Consumption

Outside Lands Becomes First-Ever California Fest to Offer Cannabis Sales, Consumption

San Francisco Music Festival, Outside Lands, will feature 28 cannabis companies to participate in Grass Lands. A Cannabis focused section of the festival. Included in Grass Lands will be a curated stage for comedy, music and cooking. San Francisco's new regulations governing temporary cannabis sales restrict consumption and sales outside of the Grass Lands area, which will be hidden from visibility from festival goers.

Fall 2019: Cornell will offer courses on the "biology, society and industry" of cannabis!

Fall 2019: Cornell will offer courses on the "biology, society and industry" of cannabis!

The course, Cannabis: Biology, Society and Industry, will give students a background in dealing with cannabis through several academic lenses and contexts. Carlyn S. Buckler, an associate professor of practice with Cornell University’s School of Integrative Plant Science, created the course to help students garner more skills within the cannabis industry. 

The CBD Industry Is Betting That Pets Need to Chill, Too

The CBD Industry Is Betting That Pets Need to Chill, Too

“Demand for CBD, a nonintoxicating compound found in hemp and marijuana, has exploded in the U.S. since December, when Congress passed a new farm bill that decriminalized industrial hemp. The CBD market could be worth almost $24 billion in the U.S. alone by 2023, with about 7% of sales coming from the pet market, according to Brightfield Group, an industry researcher.” – Bloomberg

Leading Legalization Group Unveils Report On Marijuana Policy Wins In 2019 So Far

Leading Legalization Group Unveils Report On Marijuana Policy Wins In 2019 So Far

“From marijuana legalization in Illinois to decriminalization in New Mexico, 2019 has been a banner year for the cannabis reform movement, the Marijuana Policy Project (MPP) said in a mid-year progress report published on Monday.” – Marijuana Moment

Member Login
Welcome, (First Name)!

Forgot? Show
Log In
Enter Member Area
My Profile Not a member? Sign up. Log Out